Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
McKinsey
Fish and Richardson
US Department of Justice
Harvard Business School
Cerilliant
Express Scripts
McKesson

Generated: February 20, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for LEVOCETIRIZI

« Back to Dashboard

Payment Methods and Pharmacy Types for LEVOCETIRIZI (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $10,773,413
INSIDE ANOTHER STORE $18,770,492
[disabled in preview] $46,879,450
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 529,053
INSIDE ANOTHER STORE 541,415
[disabled in preview] 2,440,104
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $2,564,836
MEDICARE $25,562,218
[disabled in preview] $48,296,300
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for LEVOCETIRIZI
Drug Units Sold Trends for LEVOCETIRIZI

Annual Sales Revenues and Units Sold for LEVOCETIRIZI

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
LEVOCETIRIZI ➤ Try a Free Trial ➤ Try a Free Trial 2016
LEVOCETIRIZI ➤ Try a Free Trial ➤ Try a Free Trial 2015
LEVOCETIRIZI ➤ Try a Free Trial ➤ Try a Free Trial 2014
LEVOCETIRIZI ➤ Try a Free Trial ➤ Try a Free Trial 2013
LEVOCETIRIZI ➤ Try a Free Trial ➤ Try a Free Trial 2012
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Merck
Daiichi Sankyo
Julphar
Cerilliant
AstraZeneca
Johnson and Johnson
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.